Nadroparine calcium or enoxaparine in acute coronary syndrome patients suffering renal insufficiency: The nadroparin versus enoxaparin (NaVe) study design.

Authors:
Gurfinkel EP; Perel C; Pombo G.

Journal:
Thromb J

Publication Year: 2004

DOI:
10.1186/1477-9560-2-6

PMCID:
PMC425600

PMID:
15186495

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Thromb J

Abbreviation: Thromb J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acute caval thrombosis leading to obstructive shock in the early post insertion period of an inferi…
Gao S; Chen Y; Huang Y and 2 more (2024) - Transparency Score: 3/6
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature re…
Liu Z; Fan L; Liang S and 2 more (2024) - Transparency Score: 3/6
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX …
Wei X; Zhang H; Chen W and 2 more (2024) - Transparency Score: 3/6
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treate…
Onelöv L; Theodorsson E; Božič-Mijovski M and 1 more (2024) - Transparency Score: 3/6
Establishment and validation of a nomogram predicting the risk of deep vein thrombosis before total…
Wang Z; Mao X; Guo Z and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"AcknowledgementsSupported: by Fundación Favaloro"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025